Drug Patents owned by Ascend Theraps Us
1. Drug name - BINOSTO
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US7964212 | ASCEND THERAPS US | Effervescent compositions comprising phosphonates and methods related thereto |
Mar, 2023
(5 months from now) | |
| US7488496 | ASCEND THERAPS US | Effervescent compositions comprising bisphosphonates and methods related thereto |
Aug, 2023
(10 months from now) | |
| EP2277503A1 | ASCEND THERAPS US | Effervescent Compositions Comprising Bisphosphonates |
Mar, 2023
(5 months from now) | |
| EP2277503B1 | ASCEND THERAPS US | Effervescent Compositions Comprising Bisphosphonates |
Mar, 2023
(5 months from now) | |
| EP1490024B1 | ASCEND THERAPS US | Effervescent Compositions Comprising Alendronate |
Mar, 2023
(5 months from now) | |
| EP1490024A1 | ASCEND THERAPS US | Effervescent Compositions Comprising Alendronate |
Mar, 2023
(5 months from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9592195 | ASCEND THERAPS US | Stable effervescent bisphosphonate formulations with rapid solubilization characteristics |
Dec, 2031
(9 years from now) | |
Drugs and Companies using ALENDRONATE SODIUM ingredient
Treatment: NA
Dosage: TABLET, EFFERVESCENT;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 70MG BASE | TABLET, EFFERVESCENT;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.